Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 2
1978 1
1979 2
1980 4
1981 1
1983 2
1986 1
1987 3
1988 3
1989 1
1992 1
1993 1
1994 2
1995 1
1996 3
1999 1
2000 1
2001 1
2002 1
2005 2
2006 3
2007 2
2008 1
2009 2
2011 1
2013 5
2014 3
2015 3
2016 5
2017 3
2018 4
2019 19
2020 14
2021 10
2022 9
2023 6
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators. Fervenza FC, et al. N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427. N Engl J Med. 2019. PMID: 31269364 Clinical Trial.
Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy.
Barbour SJ, Fervenza FC, Induruwage D, Brenchley PE, Rovin B, Hladunewich MA, Reich HN, Lafayette R, Aslam N, Appel GB, Zand L, Kiryluk K, Liu L, Cattran DC; MENTOR Trial Investigators. Barbour SJ, et al. Clin J Am Soc Nephrol. 2023 Oct 1;18(10):1283-1293. doi: 10.2215/CJN.0000000000000237. Epub 2023 Jul 20. Clin J Am Soc Nephrol. 2023. PMID: 37471101 Free PMC article.
Turcot Syndrome.
Khattab A, Monga DK. Khattab A, et al. Among authors: monga dk. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30521203 Free Books & Documents.
Male Breast Cancer.
Khattab A, Kashyap S, Monga DK. Khattab A, et al. Among authors: monga dk. 2024 Sep 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Sep 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30252292 Free Books & Documents.
Kidney diseases associated with Waldenström macroglobulinemia.
Uppal NN, Monga D, Vernace MA, Mehtabdin K, Shah HH, Bijol V, Jhaveri KD. Uppal NN, et al. Among authors: monga d. Nephrol Dial Transplant. 2019 Oct 1;34(10):1644-1652. doi: 10.1093/ndt/gfy320. Nephrol Dial Transplant. 2019. PMID: 30380110 Review.
Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials.
Barbour SJ, Ronco P, Praga M, Fervenza FC, Induruwage D, Zhu B, Debiec H, Fernández-Juárez G, Caravaca-Fontán F, Cattran DC; GEMRITUX, MENTOR and STARMEN investigators. Barbour SJ, et al. Clin J Am Soc Nephrol. 2025 Apr 14;20(6):854-865. doi: 10.2215/CJN.0000000694. Clin J Am Soc Nephrol. 2025. PMID: 40228233
Enteric encephalopathy.
Jain SK, Monga D, Goel A. Jain SK, et al. Among authors: monga d. J Indian Med Assoc. 1986 Feb;84(2):57-8. J Indian Med Assoc. 1986. PMID: 3106505 No abstract available.
121 results